1. Home
  2. JXN vs GKOS Comparison

JXN vs GKOS Comparison

Compare JXN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jackson Financial Inc.

JXN

Jackson Financial Inc.

HOLD

Current Price

$114.32

Market Cap

6.5B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$124.61

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JXN
GKOS
Founded
1961
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.3B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
JXN
GKOS
Price
$114.32
$124.61
Analyst Decision
Hold
Strong Buy
Analyst Count
5
14
Target Price
$108.80
$127.71
AVG Volume (30 Days)
469.3K
699.0K
Earning Date
02-18-2026
02-17-2026
Dividend Yield
2.90%
N/A
EPS Growth
N/A
N/A
EPS
7.31
N/A
Revenue
$4,997,000,000.00
$469,820,000.00
Revenue This Year
$113.97
$31.33
Revenue Next Year
$8.76
$24.01
P/E Ratio
$15.11
N/A
Revenue Growth
25.33
30.38
52 Week Low
$64.70
$73.16
52 Week High
$118.18
$163.71

Technical Indicators

Market Signals
Indicator
JXN
GKOS
Relative Strength Index (RSI) 60.94 68.36
Support Level $110.12 $93.96
Resistance Level $115.94 $115.00
Average True Range (ATR) 3.11 5.01
MACD -0.41 0.65
Stochastic Oscillator 70.10 99.51

Price Performance

Historical Comparison
JXN
GKOS

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: